Literature DB >> 7487058

Macrophages require both iron and copper to oxidize low-density lipoprotein in Hanks' balanced salt solution.

L Kritharides1, W Jessup, R T Dean.   

Abstract

The oxidation of low-density lipoprotein (LDL) may be important in the pathogenesis of atherosclerosis. However, the interactions between cells and metals in promoting LDL oxidation are inadequately understood. A sensitive high-performance liquid chromatography analysis of cholesterol, cholesteryl esters, and their oxidation products was used to identify and accurately measure LDL oxidation achieved in thiol-free Hanks' balanced salt solution (HBSS) at pH 7.4. Mouse peritoneal macrophages inhibited LDL oxidation when incubated in HBSS containing either 10 microM iron or 1 microM copper, but were markedly prooxidant in the presence of both metals. The prooxidant effect of macrophages in the presence of both iron and copper did not require the provision of added disulfides or thiols. Both Fe2+ and macrophages were demonstrated to independently reduce Cu2+ to Cu1+ in HBSS, indicating that the direct reduction of copper by cells or iron may underlie the observed promotion of LDL oxidation by macrophages in this system. We conclude that macrophages can either promote or inhibit metal-mediated LDL oxidation and that externally supplied thiols are not essential to the promotion of LDL oxidation by cells. The presence of both iron and copper may be particularly important for macrophages to promote LDL oxidation in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487058     DOI: 10.1006/abbi.1995.0018

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  1 in total

1.  In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques.

Authors:  Subha V Raman; Marshall W Winner; Tam Tran; Murugesan Velayutham; Orlando P Simonetti; Peter B Baker; John Olesik; Beth McCarthy; Amy K Ferketich; Jay L Zweier
Journal:  JACC Cardiovasc Imaging       Date:  2008-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.